サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1363519

ジェット式ネブライザーの市場規模、シェア、動向分析レポート：適応症別、最終用途別、地域別、セグメント予測、2023年～2030年

Pneumatic Nebulizers Market Size, Share & Trends Analysis Report By Indication (Breath-actuated, Vented), By End-use (Hospitals & Clinics, Home Healthcare), By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 140 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
ジェット式ネブライザーの市場規模、シェア、動向分析レポート：適応症別、最終用途別、地域別、セグメント予測、2023年～2030年
出版日: 2023年09月26日
発行: Grand View Research
ページ情報: 英文 140 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ジェット式ネブライザー市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のジェット式ネブライザー市場規模は2023年から2030年にかけてCAGR 6.3％を記録し、2030年には11億6,670万米ドルに達すると予測されています。

同市場は、近年在宅ヘルスケア機器の普及に伴い、ジェット式ネブライザーの採用が一定の伸びを示しています。製品の小型化や技術の進歩も在宅ヘルスケア機器の採用を後押ししています。

ミネソタ州保健省によれば、ネブライザーを使った薬剤投与は、他のエアロゾルを発生させる処置に比べて感染リスクが低いです。一方、ISAMによれば、ネブライザーからのエアロゾルは、ネブライザー室内の液体から発生するため、患者に由来するウイルス粒子を運ぶことはないです。ネブライザーから発生するエアロゾルが病原体を含むのは、ヘルスケアワーカーまたは患者がネブライザーを汚染した場合に限られます。パンデミック時にネブライザーを使用することが適切かどうかについては、各機関のさまざまな勧告でも明らかにされていないです。

しかし、ネブライザーによる受動感染の事例は知られていないです。また、もし感染の危険があるとしても、COVID-19の適切な予防措置をとれば回避できます。したがって、パンデミックは市場全体に一定の影響を与えたに過ぎないです。革命的な技術進歩が市場を急速に変化させています。こうした拡大は、有利な可能性を生み出しています。例えば、2019年3月、Breath Technologies社は、調査中のPARI Pharma社の薬剤特異的eFlowネブライザーを介した閉塞性細気管支炎症候群の治療に対するL-CSA-iの第3相BOSTON臨床試験の開始を発表しました。

ジェット式ネブライザー市場レポートハイライト：

  • 呼吸作動製品セグメントは、製品需要の増加により、2022年に64.2%以上の圧倒的な収益シェアを占めました。
  • 病院・クリニックのエンドユースセグメントは、病院・クリニックでの高い製品使用により、2022年に65%以上の収益シェアで市場を独占しました。
  • 北米は、呼吸器疾患の有病率の増加と製品採用率の高さにより、2022年に35.54%以上の最大収益シェアを占めました。
  • アジア太平洋地域は、中国やインドなどの新興国の存在により、予測期間中のCAGRが7.4%で最も急成長する地域と予想されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 ジェット式ネブライザー市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 普及と成長の見通しマッピング
  • 業界のバリューチェーン分析
    • 償還の枠組み
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因分析
  • ジェット式ネブライザー市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 ジェット式ネブライザー：適応症別推定と推定・動向分析

  • ジェット式ネブライザー市場：重要なポイント
  • ジェット式ネブライザー市場：動向と市場シェア分析、2022年および2030年
  • 吸気同調
  • 通気式

第5章 ジェット式ネブライザー：最終用途別推定・動向分析

  • ジェット式ネブライザー市場：重要なポイント
  • ジェット式ネブライザー市場：動向と市場シェア分析、2022年および2030年
  • 病院とクリニック
  • 在宅ヘルスケア

第6章 ジェット式ネブライザー：地域別推定・動向分析

  • 地域別の展望
  • 地域別のジェット式ネブライザー市場：重要なポイント
  • 北米
    • 市場推計・予測、2018～2030年
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 市場参入企業の分類
    • Koninklijke Philips N.V.
    • OMRON Corporation
    • PARI GmbH
    • General Electric
    • Allied Healthcare Products, Inc.
    • BD (Becton, Dickinson and Company)
    • GF Health Products, Inc.
    • Medline Industries, LP
    • Briggs Healthcare
    • Vectura Group Ltd
図表

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 3 North America pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 4 North America pneumatic nebulizers market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 6 U.S. pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 7 Canada pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 8 Canada pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Europe pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 10 Europe pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Europe pneumatic nebulizers market, by region, 2018 - 2030 (USD Million)
  • Table 12 UK pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 13 UK pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 14 Germany pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 15 Germany pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 16 France pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 17 France pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 18 Italy pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 19 Italy pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Spain pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 21 Spain pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 22 Denmark pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 23 Denmark pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Sweden pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 25 Sweden pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 26 Norway pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 27 Norway pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific pneumatic nebulizers market, by region, 2018 - 2030 (USD Million)
  • Table 31 Japan pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 32 Japan pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 33 China pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 34 China pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 35 India pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 36 India pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Australia pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 38 Australia pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 39 Thailand pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 40 Thailand pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 41 South Korea pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 42 South Korea pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Latin America pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 44 Latin America pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 45 Latin America pneumatic nebulizers market, by region, 2018 - 2030 (USD Million)
  • Table 46 Brazil pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 47 Brazil pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Mexico pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 49 Mexico pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Argentina pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 51 Argentina pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 54 Middle East and Africa pneumatic nebulizers market, by region, 2018 - 2030 (USD Million)
  • Table 55 South Africa pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 56 South Africa pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 59 UAE pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 60 UAE pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Kuwait pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 62 Kuwait pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Pneumatic nebulizers: Market outlook
  • Fig. 8 Pneumatic nebulizers: Competitive insights
  • Fig. 9 Parent market outlook
  • Fig. 10 Related/ancillary market outlook
  • Fig. 11 Penetration and growth prospect mapping
  • Fig. 12 Pneumatic nebulizers market driver impact
  • Fig. 13 Pneumatic nebulizers market restraint impact
  • Fig. 14 Pneumatic nebulizers market strategic initiatives analysis
  • Fig. 15 Pneumatic nebulizers market: Indication movement analysis
  • Fig. 16 Pneumatic nebulizers market: Indication outlook and key takeaways
  • Fig. 17 Breath-actuated market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Vented market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Pneumatic nebulizers market: End use movement analysis
  • Fig. 20 Pneumatic nebulizers market: End use outlook and key takeaways
  • Fig. 21 Hospital and clinics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Home healthcare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Global pneumatic nebulizers market: Regional movement analysis
  • Fig. 24 Global pneumatic nebulizers market: Regional outlook and key takeaways
  • Fig. 25 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
目次
Product Code: GVR-1-68038-194-8

Pneumatic Nebulizers Market Growth & Trends:

The global pneumatic nebulizers market size is expected to reach USD 1,166.7 million by 2030, registering a CAGR of 6.3% from 2023 to 2030, according to a new report by Grand View Research, Inc.. The market has shown constant growth in the adoption of pneumatic nebulizers as home healthcare devices have been gaining popularity in recent years. Miniaturization of products and technological advancements are also boosting the adoption of home healthcare devices.

As per the Minnesota Department of Health, administration of medication through nebulizer represents a lower infection risk as compared to other aerosol-producing procedures. On the other hand, according to ISAM, aerosols from the nebulizer do not carry viral particles derived from the patient as they are generated from the fluid in the nebulized chamber, which is a non-patient source. Aerosols generated by nebulizers comprise pathogens only when the healthcare workers or patients contaminate the nebulizers. Various recommendations from institutes do not clarify whether it is appropriate to use nebulizers during the pandemic.

However, there are no known cases of passive infection due to nebulizers. Also, the risk of infection, if any, can be avoided if proper COVID-19 precautions are taken. Therefore, the pandemic affected the overall market only to a certain extent. Revolutionary technological progress is rapidly transforming the market. These expansions are producing lucrative potentials. For instance, in March 2019, Breath Technologies announced the initiation of Phase 3 BOSTON clinical study of L-CsA-i for the treatment of bronchiolitis obliterans syndrome via a drug-specific eFlow nebulizer of PARI Pharma that is under investigation.

Pneumatic Nebulizers Market Report Highlights:

  • The breath-actuated product segment held the dominant revenue share of over 64.2% in 2022 owing to the increased product demand
  • The hospitals & clinics end-use segment dominated the market in 2022 with a revenue share of more than 65% owing to the high product usage a hospitals & clinics
  • North America accounted for the largest revenue share of more than 35.54% in 2022 owing to the increased prevalence of respiratory diseases and high product adoption
  • Asia Pacific is expected to be the fastest-growing region, with a CAGR of 7.4% over the forecast period owing to the presence of emerging countries, such as China and India

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Indication
    • 1.1.2. End use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Indication outlook
    • 2.2.2. End use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Pneumatic Nebulizers Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market driver analysis
    • 3.4.2. Market restraint analysis
  • 3.5. Pneumatic Nebulizers Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic landscape

Chapter 4. Pneumatic Nebulizers: Indication Estimates & Trend Analysis

  • 4.1. Pneumatic Nebulizers Market: Key Takeaways
  • 4.2. Pneumatic Nebulizers Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Breath-Actuated
    • 4.3.1. Breath-Actuated market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Vented
    • 4.4.1. Vented market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Pneumatic Nebulizers: End use Estimates & Trend Analysis

  • 5.1. Pneumatic Nebulizers Market: Key Takeaways
  • 5.2. Pneumatic Nebulizers Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Hospitals & Clinics
    • 5.3.1. Hospitals & Clinics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Home Healthcare
    • 5.4.1. Home Healthcare market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Pneumatic Nebulizers: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Pneumatic Nebulizers Market by Region: Key Takeaways
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Denmark
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Norway
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. South Africa
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. Koninklijke Philips N.V.
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. OMRON Corporation
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. PARI GmbH
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. General Electric
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Allied Healthcare Products, Inc.
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. BD (Becton, Dickinson and Company)
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. GF Health Products, Inc.
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Medline Industries, LP
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. Briggs Healthcare
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. Vectura Group Ltd
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives